Kyung Dong Pharmaceutical Co. Ltd (011040) — Cash Flow Quality Index
Kyung Dong Pharmaceutical Co. Ltd (011040) has a Cash Flow Quality Index of 0.82x as of June 2026. Operating cash flow of ₩4.75 Billion is below net income of ₩5.78 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore debt repayment capacity of Kyung Dong Pharmaceutical Co. Ltd to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Kyung Dong Pharmaceutical Co. Ltd Cash Flow Quality Index (2011–2025)
Historical Cash Flow Quality Index for Kyung Dong Pharmaceutical Co. Ltd across 14 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash flow conversion of Kyung Dong Pharmaceutical Co. Ltd.
Annual Cash Flow Quality Index for Kyung Dong Pharmaceutical Co. Ltd (2011–2025)
Year-by-year earnings quality comparison for Kyung Dong Pharmaceutical Co. Ltd.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.99x | ₩16.93 Billion | ₩8.53 Billion | ▲ +234.0% |
| 2024 | -1.48x | ₩-8.07 Billion | ₩5.45 Billion | ▼ -1576.7% |
| 2022 | -0.09x | ₩-1.07 Billion | ₩12.16 Billion | ▼ -109.0% |
| 2021 | 0.98x | ₩12.42 Billion | ₩12.67 Billion | ▼ -28.6% |
| 2020 | 1.37x | ₩17.12 Billion | ₩12.46 Billion | ▲ +1094.3% |
| 2019 | -0.14x | ₩-2.78 Billion | ₩20.13 Billion | ▼ -102.2% |
| 2018 | 6.35x | ₩33.27 Billion | ₩5.24 Billion | ▲ +768.0% |
| 2017 | 0.73x | ₩14.79 Billion | ₩20.23 Billion | ▼ -49.8% |
| 2016 | 1.46x | ₩25.63 Billion | ₩17.61 Billion | ▲ +12.7% |
| 2015 | 1.29x | ₩18.26 Billion | ₩14.13 Billion | ▲ +39.4% |
| 2014 | 0.93x | ₩22.73 Billion | ₩24.52 Billion | ▲ +6.4% |
| 2013 | 0.87x | ₩16.42 Billion | ₩18.85 Billion | ▼ -64.1% |
| 2012 | 2.43x | ₩19.96 Billion | ₩8.22 Billion | ▲ +88.9% |
| 2011 | 1.28x | ₩26.08 Billion | ₩20.29 Billion | — |